Search details
1.
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study.
Clin Gastroenterol Hepatol
; 22(1): 102-112.e9, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37088457
2.
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study.
Clin Gastroenterol Hepatol
; 22(1): 113-123.e9, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37088458
3.
BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial.
Hepatology
; 75(4): 912-923, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34605045
4.
Evaluation of selective inhibitors of 11ß-HSD1 for the treatment of hypertension.
Bioorg Med Chem Lett
; 23(12): 3650-3, 2013 Jun 15.
Article
in English
| MEDLINE | ID: mdl-23659858
5.
Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
JHEP Rep
; 4(1): 100392, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34977519
6.
SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH.
Hepatol Commun
; 5(5): 760-773, 2021 May.
Article
in English
| MEDLINE | ID: mdl-34027267
7.
PRO-C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD.
Hepatol Commun
; 5(11): 1860-1872, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34558828
8.
The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis.
Contemp Clin Trials
; 104: 106335, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33657443
9.
The safety and pharmacokinetics of a novel, selective S1P1R modulator in healthy participants.
Expert Opin Investig Drugs
; 29(4): 411-422, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32306792
10.
Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects.
J Clin Pharmacol
; 57(2): 161-172, 2017 02.
Article
in English
| MEDLINE | ID: mdl-27402064
11.
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).
Proc Natl Acad Sci U S A
; 102(23): 8132-7, 2005 Jun 07.
Article
in English
| MEDLINE | ID: mdl-15928087
Results
1 -
11
de 11
1
Next >
>>